Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
20.20
+0.47 (2.38%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Fulgent Genetics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 556 | 812 | 565 | 857 | 900 | 3,001 | |
Market Cap Growth | -17.54% | 43.74% | -34.06% | -4.82% | -70.00% | 137.28% |
Enterprise Value | 14 | 27 | -244 | 28 | 26 | 2,160 |
Last Close Price | 20.20 | 26.27 | 18.47 | 28.91 | 29.78 | 100.59 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 6.28 | 5.91 |
Forward PE | - | 247.16 | 247.16 | 247.16 | 247.16 | 13.80 |
PS Ratio | 1.72 | 2.52 | 1.99 | 2.96 | 1.45 | 3.02 |
PB Ratio | 0.55 | 0.73 | 0.50 | 0.76 | 0.71 | 2.57 |
P/TBV Ratio | 0.70 | 0.85 | 0.58 | 0.88 | 0.93 | 2.80 |
P/FCF Ratio | - | - | - | 178.63 | 3.83 | 5.83 |
P/OCF Ratio | - | - | 26.83 | 31.73 | 3.55 | 5.57 |
PEG Ratio | - | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.04 | 0.09 | - | 0.10 | 0.04 | 2.18 |
EV/EBITDA Ratio | - | - | - | - | 0.12 | 3.14 |
EV/EBIT Ratio | - | - | - | - | 0.14 | 3.20 |
EV/FCF Ratio | - | - | - | 5.91 | 0.11 | 4.20 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 |
Debt / EBITDA Ratio | - | - | - | - | 0.17 | 0.04 |
Debt / FCF Ratio | - | - | - | 3.45 | 0.16 | 0.06 |
Net Debt / Equity Ratio | -0.54 | -0.63 | -0.73 | -0.73 | -0.64 | -0.78 |
Net Debt / EBITDA Ratio | 6.06 | 10.72 | 16.72 | 16.91 | -3.80 | -1.32 |
Net Debt / FCF Ratio | 5.22 | 5.61 | 42.55 | -173.30 | -3.47 | -1.76 |
Asset Turnover | 0.28 | 0.27 | 0.23 | 0.22 | 0.47 | 1.00 |
Quick Ratio | 4.57 | 5.03 | 4.60 | 6.60 | 6.83 | 5.64 |
Current Ratio | 6.34 | 6.48 | 4.85 | 6.96 | 7.13 | 5.81 |
Return on Equity (ROE) | -8.11% | -5.51% | -3.87% | -14.58% | 11.65% | 58.35% |
Return on Assets (ROA) | -6.30% | -4.58% | -3.76% | -3.59% | 8.51% | 42.69% |
Return on Invested Capital (ROIC) | -15.10% | -10.75% | -9.21% | -9.99% | 18.33% | 97.45% |
Return on Capital Employed (ROCE) | -11.30% | -7.90% | -6.40% | -6.50% | 14.00% | 57.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -15.18% | -7.45% | -7.56% | -19.59% | 15.93% | 16.91% |
FCF Yield | -18.67% | -15.30% | -3.41% | 0.56% | 26.08% | 17.16% |
Buyback Yield / Dilution | 1.51% | -1.79% | -1.51% | 3.81% | 0.04% | -28.77% |